| UCB-Pharma SA - Neupro 4 mg/24h, dispositif transdermique | | 57417 | | 02 | | Neupro 4 mg/24h | | dispositif transdermique | | N04BC09 | | Rotigotine | | 27.09.2006 | | |
| | Composition | | rotigotinum 9 mg, antiox.: E 223, E 304, excipiens ad praeparationem pro 20 cm², cum liberatione 4 mg/24h. | | Packungsbestandteile | | dispositif transdermique | | | |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
|
